Presentation

Company Profile
Össur is a global leader in non-invasive orthopaedics; developing, producing, and providing advanced technological solutions within the prosthetics and bracing & supports market. Prosthetic products include artificial limbs and related products for amputees. Bracing & supports products are primarily used to support joints and other body parts, both for preventive and therapeutic purposes. Every year Össur invests the equivalent of 5% of sales in R&D efforts to work on new innovative products with 20 new product launches being made in 2020 alone. Össur was founded in 1971, has been listed since 1999 and has operations in over 30 countries with more than 3,500 FTEs.

Recent highlights
In Q2 2021, Össur reported net sales of USD 190 million (135) demonstrating a reported growth of 41% y/y, while the organic growth was 32%. EBITDA for Q2 was USD 42 million (12) with an EBITDA margin of 22% (9). Net profit for Q2 2021 was USD 19 million (-18). The company noted that the impact of COVID-19 has diminished, but it still varies by geography. In February 2021, Össur announced that the company will be carbon neutral in 2021 for energy and fuel consumption, waste generation, business travel, transportation of goods, and electricity consumption of finished goods suppliers. In Q2 2021, Össur completed acquisitions of entities with combined annual sales of USD 11 million.

Outlook
Össur’s strategy is based upon three pillars. Firstly, to continue being innovative, and keep bringing new products to the market; secondly, to maintain sustainable growth by successfully commercialising their innovation and expanding their business; finally, to increase efficiency in their operations.